• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐血来源和外周血来源的细胞因子诱导的杀伤细胞对 Fas 介导的凋亡敏感。

Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.

机构信息

CHU Sainte-Justine Research Center, Center of Cancerology Charles-Bruneau, Montreal, Quebec, Canada.

出版信息

Biol Blood Marrow Transplant. 2013 Sep;19(9):1407-11. doi: 10.1016/j.bbmt.2013.07.007. Epub 2013 Jul 12.

DOI:10.1016/j.bbmt.2013.07.007
PMID:23856078
Abstract

Fas-mediated apoptosis is one of the mechanisms used by tumor cells to escape the cytotoxicity of tumor-infiltrating lymphocytes. It has been suggested that cytokine-induced killer (CIK) cells are resistant to Fas-mediated apoptosis, thereby rendering them more attractive for use in cellular immunotherapy. Unlike what was observed by others, here we show that CIK cells are sensitive to Fas-mediated apoptosis. We have observed an increase in Fas expression in the different CIK cell subpopulations (CD3(+)CD56(-), CD3(+)CD56(+), and CD3(-)CD56(+)) isolated from both cord blood (CB) and peripheral blood (PB). We also show that the bulk, as well as the CD3(+)CD56(-) and CD56(+) CB- and PB-CIK cell subpopulations were sensitive to Fas-mediated apoptosis induced by both CH11 and APO-1 antibodies, albeit with a weaker effect for the CH11 antibody on CB-CIK cells. In addition, in the presence of the APO-1 and CH11 inducers, Fas engagement inhibited the cytotoxic activity of CB- and PB-CIK cells. This new contradictory result may help explain the variable efficacy observed with CIK cells in the clinic.

摘要

Fas 介导的细胞凋亡是肿瘤细胞逃避肿瘤浸润淋巴细胞细胞毒性的机制之一。有人认为细胞因子诱导的杀伤(CIK)细胞对 Fas 介导的细胞凋亡具有抗性,从而使其更适合用于细胞免疫治疗。与其他人观察到的不同,我们在这里显示 CIK 细胞对 Fas 介导的细胞凋亡敏感。我们已经观察到从脐带血(CB)和外周血(PB)分离的不同 CIK 细胞亚群(CD3(+)CD56(-)、CD3(+)CD56(+)和 CD3(-)CD56(+))中 Fas 表达增加。我们还表明, bulk 以及 CD3(+)CD56(-)和 CD56(+)CB 和 PB-CIK 细胞亚群对 CH11 和 APO-1 抗体诱导的 Fas 介导的细胞凋亡敏感,尽管 CH11 抗体对 CB-CIK 细胞的作用较弱。此外,在 APO-1 和 CH11 诱导剂存在下,Fas 结合抑制了 CB 和 PB-CIK 细胞的细胞毒性活性。这一新的矛盾结果可能有助于解释临床上观察到的 CIK 细胞疗效的可变性。

相似文献

1
Cord blood-derived and peripheral blood-derived cytokine-induced killer cells are sensitive to Fas-mediated apoptosis.脐血来源和外周血来源的细胞因子诱导的杀伤细胞对 Fas 介导的凋亡敏感。
Biol Blood Marrow Transplant. 2013 Sep;19(9):1407-11. doi: 10.1016/j.bbmt.2013.07.007. Epub 2013 Jul 12.
2
Implication of different effector mechanisms by cord blood-derived and peripheral blood-derived cytokine-induced killer cells to kill precursor B acute lymphoblastic leukemia cell lines.脐血来源和外周血来源的细胞因子诱导的杀伤细胞通过不同效应机制对前体 B 急性淋巴细胞白血病细胞系的杀伤作用。
Cytotherapy. 2014 Jun;16(6):845-56. doi: 10.1016/j.jcyt.2013.12.010. Epub 2014 Feb 12.
3
Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.脐血来源的细胞因子诱导杀伤细胞的表型特征及抗肿瘤作用
Cytotherapy. 2015 Jan;17(1):86-97. doi: 10.1016/j.jcyt.2014.09.006. Epub 2014 Oct 24.
4
Pseudomonas aeruginosa injection enhanced antitumor cytotoxicity of cytokine-induced killer cells derived from cord blood.铜绿假单胞菌注射液增强了脐血来源的细胞因子诱导杀伤细胞的抗肿瘤细胞毒性。
Biomed Pharmacother. 2014 Oct;68(8):1057-63. doi: 10.1016/j.biopha.2014.10.024. Epub 2014 Oct 31.
5
Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.人干扰素-α增强 CD56(+)脐血来源细胞因子诱导的杀伤细胞对人 B 急性淋巴细胞白血病细胞系的细胞毒性作用。
Cytotherapy. 2012 Nov;14(10):1245-57. doi: 10.3109/14653249.2012.714864. Epub 2012 Sep 14.
6
The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.细胞因子诱导的杀伤细胞的双重功能特性及其在肿瘤免疫学中的应用。
Hum Immunol. 2015 May;76(5):385-91. doi: 10.1016/j.humimm.2014.09.021. Epub 2014 Oct 8.
7
Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.脐带血来源的细胞因子诱导的杀伤细胞生物治疗联合二线化疗治疗晚期实体恶性肿瘤。
Int Immunopharmacol. 2011 Apr;11(4):449-56. doi: 10.1016/j.intimp.2010.12.014. Epub 2011 Jan 5.
8
[Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].[在临床级培养方案中,胸腺球蛋白可有效扩增细胞因子诱导的杀伤细胞]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jul;30(7):681-5, 690.
9
CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo.来自复发或难治性 AML 患者的 CIK 细胞可在体外有效扩增,并用于减少体内白血病细胞。
Exp Hematol. 2013 Mar;41(3):241-52.e3. doi: 10.1016/j.exphem.2012.10.014. Epub 2012 Oct 30.
10
[Induction of dendritic cells from intra-operative lost blood and their effects on CIK against liver cancer cells in vitro].[术中失血诱导树突状细胞及其对体外CIK抗肝癌细胞的影响]
Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):759-63.

引用本文的文献

1
Clinical Trials with Combination of Cytokine-Induced Killer Cells and Dendritic Cells for Cancer Therapy.细胞因子诱导的杀伤细胞和树突状细胞联合用于癌症治疗的临床试验。
Int J Mol Sci. 2019 Sep 3;20(17):4307. doi: 10.3390/ijms20174307.
2
Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.脐带血来源的树突状细胞加细胞因子诱导的杀伤细胞联合化疗治疗晚期胃癌患者的疗效和安全性:一项随机II期研究。
Onco Targets Ther. 2016 Jul 25;9:4617-27. doi: 10.2147/OTT.S107745. eCollection 2016.
3
The cytotoxic action of the CD56+ fraction of cytokine-induced killer cells against a K562 cell line is mainly restricted to the natural killer cell subset.
细胞因子诱导的杀伤细胞 CD56+ 亚群对 K562 细胞系的细胞毒性作用主要局限于自然杀伤细胞亚群。
Blood Transfus. 2017 Jan;15(1):93-100. doi: 10.2450/2016.0263-15. Epub 2016 Mar 21.